Graeme Currie

Dr. Currie has over 30 years of drug development experience in both pharmaceutical and biotechnology companies, having held senior leadership roles at Dynavax, Regeneron Pharmaceuticals, Sepracor Inc., PDL Biopharma and Gilead Sciences. Most recently, he was Chief Development Officer of Tolerion Inc. Dr. Currie has successfully led drug development programs and has held key roles in the development of 8 approved drugs.

Dr. Currie holds a PhD from Aston University in the UK.


Org chart

Sign up to view 1 direct report

Get started


Teams

This person is not in any teams